ClinicalTrials.gg
CompletedNCT06555484Updated Jan 31, 2025

Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers

An interventional study of Cross Over Assignment Supplemental Oxygen and Supplemental Air in Cognition, sponsored by Inogen Inc.. Completed at 1 site in United States. Open to participants aged 22 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-31.

Sponsored by Inogen Inc. · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was Oct 2024, 2 years ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
22 Years to 80 Years
Sex
All
01

Study summary

Forty healthy adults (i.e., not recruited with respect to any particular diagnosis) are each alternately provided with supplemental oxygen and air via nasal cannula at about 6 Liters per Minute (LPM), while completing memory tests.

Read the detailed description

Prior studies have reported that supplemental oxygen can confer acute benefits to cognition. Here, the investigators seek to replicate/extend such findings by assessing whether such benefits can be seen using an Inogen oxygen concentrator with subjects with an average age around 65 years old. The investigators include a standard measure of cognition previously reported to be sensitive to supplemental oxygen (2-back test) and a novel, in-development adaptation of a memory test for medical-related content (Medical icons spatial test).

02

Conditions studied

  • Cognition

Browse trials for

Keywords

  • Oxygen Concentrator
  • Hyperoxia
03

In context

Hyperoxia

115 studies on the registry are indexed under Hyperoxia; 13 are open to participants now.

This study's enrollment of 40 is below the median of 48 across 82 interventional studies indexed under Hyperoxia.

Browse Hyperoxia studies →

Lead sponsor

Inogen Inc. is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Subjects are intended to represent "healthy adults." Patients will include a mix of self-reported gender and ethnic/racial identification.

  1. Provision of signed and dated form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Adult (aged 22+)

Exclusion criteria

Exclusion Criteria:

  • Patients who self-report diagnosis of respiratory-related conditions will be excluded.
  • Subjects with a known polyvinyl chloride (PVC) allergy will be excluded, due to potential use of a standard, PVC-based cannula in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Other
    Air First

    All study participants, completing memory tests while breathing either supplemental oxygen followed by air, or breathing air followed oxygen.

    Device: Cross Over Assignment Supplemental Oxygen and Supplemental Air

  • Other
    Oxygen First

    All study participants, completing memory tests while breathing either supplemental oxygen followed by air, or breathing air followed oxygen.

    Device: Cross Over Assignment Supplemental Oxygen and Supplemental Air

Interventions

  • DeviceCross Over Assignment Supplemental Oxygen and Supplemental Air

    Subjects repeatedly complete memory tests, either first while breathing supplemental oxygen or first while breathing "supplemental air" (in an order randomly assigned).

06

What researchers measure

Primary outcomes

  1. 2 back Memory test performance

    # correct on 2-back test

    Time frame: At baseline and 5 mins post-intervention exposure

  2. Memory test performance

    New Medical Icons Spatial Test

    Time frame: At baseline and 5 mins post-intervention exposure

07

Study locations

1 site
  • Two Liberty Place
    Philadelphia, Pennsylvania 19102, United States
08

References and documents

Publications

  • Choi MH, Kim HJ, Kim JH, Kim HS, Choi JS, Yi JH, Tack GR, Chung YS, Son I, Chung SC. Correlation between cognitive ability measured by response time of 1-back task and changes of SpO2 by supplying three different levels of oxygen in the elderly. Geriatr Gerontol Int. 2013 Apr;13(2):384-7. doi: 10.1111/j.1447-0594.2012.00911.x. Epub 2012 Jul 23. PubMed 22817401 ↗
  • Chung SC, Kwon JH, Lee HW, Tack GR, Lee B, Yi JH, Lee SY. Effects of high concentration oxygen administration on n-back task performance and physiological signals. Physiol Meas. 2007 Apr;28(4):389-96. doi: 10.1088/0967-3334/28/4/005. Epub 2007 Mar 7. PubMed 17395994 ↗
  • McMorris T, Hale BJ, Barwood M, Costello J, Corbett J. Effect of acute hypoxia on cognition: A systematic review and meta-regression analysis. Neurosci Biobehav Rev. 2017 Mar;74(Pt A):225-232. doi: 10.1016/j.neubiorev.2017.01.019. Epub 2017 Jan 19. Erratum In: Neurosci Biobehav Rev. 2019 Mar;98:333. doi: 10.1016/j.neubiorev.2019.01.017. PubMed 28111267 ↗
  • Sohn JH, Chung SC, Jang EH. 30% oxygen inhalation enhances cognitive performance through robust activation in the brain. J Physiol Anthropol Appl Human Sci. 2005 Jan;24(1):51-3. doi: 10.2114/jpa.24.51. PubMed 15684544 ↗
  • Shaw DM, Bloomfield PM, Gant N. The effect of acute normobaric hyperoxia on cognition: A systematic review, meta-analysis and meta-regression. Physiol Behav. 2023 Aug 1;267:114208. doi: 10.1016/j.physbeh.2023.114208. Epub 2023 Apr 29. PubMed 37121344 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06555484
Lead sponsor
Inogen Inc.
Responsible party
Sponsor
First posted
Aug 15, 2024
Start date
May 28, 2024
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024
Last update
Jan 31, 2025

Study contacts

Marc Egeth
principal investigator · Inogen Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion